Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1069-1072

  Dien, Tran Khac ^a,b   De Vries, Peter J ^b   Khanh, Nguyen Xuan ^a   Koopmans, Richard ^b   Binh, Le Nguyen ^c   Duc, Dao Dinh ^a   Kager, Piet A ^b   Van Boxtel, Chris J ^b  

^a BACH MAI HOSPITAL   (Viet Nam)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Inst Malariology   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALARIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0013612468     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1069     Document Type: Article

References (25)

1. China Cooperative Research Group on Qinghaosu. 1982. Studies on the toxicity of qinghaosu and its derivatives. J. Tradit. Chin. Med. 2:31-38.
2. De Vries, P. J., P. de Hooge, J. B. L. Hoekstra, and J. van Hattum. 1994. Blunted postprandial reaction of portal venous flow in chronic liver disease, assessed with duplex Doppler: significance for prognosis. J. Hepatol. 21:966-973.
3. De Vries, P. J., T. K. Dien, N. X. Khan, L. N. Binh, P. T. Yen, D. D. Duc, C. J. van Boxtel, and P. A. Kager. The pharmacokinetics of a single dose of artemisinin in patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg., in press.
4. Duc, D. D., P. J. de Vries, N. X. Khanh, L. N. Binh, C. J. van Boxtel, and P. A. Kager. 1994. The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am. J. Trop. Med. Hyg. 51:785-790.
5. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York, N.Y.
6. 3H]dihydroartemisinine by erythrocytcs infected with Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 78:265-270.
7. Hassan Alin, M., M. Ashton, C. M. Kihamia, G. J. B. Mtey, and A. Björkman. 1996. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. 90:61-65.
8. Hassan Alin, M., A. Björkman, and M. Ashton. 1990. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 84:635-637.
9. Hassan Alin, M., A. Björkman, A. Landberg-Lindgren, and M. Ashton. 1992. The effect of artemisinin, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 86:365-367.
10. Hien, T. T. 1994. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl.):S1/7-S1/8.
11. Hien, T. T., and N. J. White. 1993. Qinghaosu. Lancet 341:603-608.
12. Kager, P. A., M. J. Schultz, E. E. Zijlstra, B. van de Berg, and C. J. van Boxtel. 1994. Arteether administration in man, study of safety and tolerance and a preliminary pharmacokinetic study. Trans. R. Soc. Trop. Med. Hyg. 88 (Suppl.):53-55.
13. Klayman, D. L. 1985. Qinghaosu (artemisinin): an antimalaria drug from China. Science 228:1049-1055.
14. Kornhauser, D. M., A. J. J. Wood, R. E. E. Vestal, G. R. Wilkinson, R. A. Branch, and D. G. Shand. 1978. Biological determinants of propranolol disposition in man. Clin. Pharmacol. Ther. 23:165-174.
15. Lee, I. S., and C. D. Hufford. 1990. Metabolism of antimalarial sesquiterpene lactones. Pharm. Ther. 48:345-355.
16. Leskovac, V., and A. D. Theoharides. 1991. Hepatic metabolism of artemisinin drugs. I. Drug metabolism in rat liver microsomes. Comp. Biochem. Physiol. 99C:383-390.
17. Li, G. Q., X. B. Guo, L. C. Fu, H. X. Jian, and X. H. Wang. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl.):S1/5-S1/6.
18. -3H). hypoxanthine by Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 77:522-523.
19. Looareesuwan, S. 1994. Overview of clinical studies on artemisinin derivatives in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl.):S1/9-S1/11.
20. Melendez, V., J. O. Peggins, T. G. Brewer, and A. D. Theoharides. 1991. Determination of artemisinin and its deethylated metabolite dihydroartemisinin in plasma by high performance liquid chromatography with reductive electrochemical detection. J. Pharm. Sci. 80:132-138.
21. Niu, X., L. Ho, R. Zhihong, and Z. Song. 1985. Metabolic fate of qinghaosu in rats: a new TLC densitometric method for its determination in biological material Eur. J. Drug Metab. Pharmacokinet. 10:55-59.
22. Sy, N. D., D. B. Hoan, N. P. Dung, N. V. Huong, L. N. Binh, M. V. Son, and R. M. Steven. 1993. Treatment of malaria in Vietnam with oral artemisinin. Am. J. Trop. Med. Hyg. 48:398-402.
23. Thaithong, S., and G. G. H. Beale. 1985. Susceptibility of Thai isolates of Plasmodium falciparum to artemisinin (qinghaosu) and artemether. Bull. W.H.O. 63:617-619.
24. Welling, P. G. 1984. Interactions affecting drug absorption. Clin. Pharmacokinet. 9:404-434.
25. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175.